AI assistant
Sending…
Moleculin Biotech, Inc. — Director's Dealing 2016
Aug 23, 2016
34881_dirs_2016-08-23_9df52dae-e2cd-45b3-92b0-5cd970d4c461.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2016-08-19
Reporting Person: Foster Jonathan P. (Exec. Vice President and CFO)
More from Moleculin Biotech, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 15